Tempus AI Stock (NASDAQ:TEM)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$64.49

52W Range

$31.36 - $91.45

50D Avg

$62.78

200D Avg

$54.21

Market Cap

$10.42B

Avg Vol (3M)

$12.73M

Beta

5.17

Div Yield

-

TEM Company Profile


Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2,400

IPO Date

Jun 14, 2024

Website

TEM Performance


TEM Financial Summary


Dec 23Dec 22Dec 21
Revenue$531.82M$320.67M$257.85M
Operating Income$-196.08M$-269.14M$-243.98M
Net Income$-214.12M$-289.81M$-259.19M
EBITDA$-133.33M$-238.73M$-220.10M
Basic EPS$-3.38$-4.60$-4.12
Diluted EPS$-3.38$-4.60$-4.12

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q1 25May 06, 25 | 4:30 PM
Q4 24Feb 24, 25 | 4:30 PM
Q3 24Nov 09, 24 | 4:30 PM